Combined Ab interno viscocanaloplasty (ABiC) in open-angle glaucoma: 12-month outcomes.

Kevin GillmannAmr ArefLaëtitia Jessy NiegowskiJean-Marc Baumgartner

Published in: International ophthalmology (2021)

ABIC achieved a statistically significant reduction in IOP and anti-glaucoma medications through 12 months, while maintaining a favourable safety profile in mild-to-severe open-angle glaucoma.

Keyphrases

early onset
optic nerve
type diabetes
adipose tissue
insulin resistance
skeletal muscle
cataract surgery
glycemic control
weight loss